Genetic Diversity of SARS-CoV-2 among Travelers Arriving in Hong Kong
Haogao Gu
1, Daniel K.W. Chu
1, Lydia D.J. Chang, Sammi S.Y. Cheuk, Shreya Gurung, Pavithra Krishnan, Daisy Y.M. Ng, Gigi Y.Z. Liu, Carrie K.C. Wan, Ruopeng Xie, Samuel S.M. Cheng, Benjamin J. Cowling, Dominic N.C. Tsang, Malik Peiris, Vijaykrishna Dhanasekaran, and Leo L.M. Poon
Author affiliations: School of Public Health, University of Hong Kong, Hong Kong, China (H. Gu, D.K.W. Chu, L.D.J. Chang, S.S.Y. Cheuk, S. Gurung, P. Krishnan, D.Y.M. Ng, G.Y.Z. Liu, C.K.C. Wan, R. Xie, S.S.M. Cheng, B.J. Cowling, M. Peiris, V. Dhanasekaran, L.L.M. Poon); Department of Health Centre for Health Protection, Government of Hong Kong Special Administrative Region, Hong Kong (D.N.C. Tsang); HKU-Pasteur Research Pole, University of Hong Kong, Hong Kong (M. Peiris, V. Dhanasekaran, L.L.M. Poon)
Main Article
Table 1
Severe acute respiratory syndrome coronavirus 2 variants of concern and variants of interest identified in imported cases in Hong Kong, January 2020–March 2021
Pango lineage |
Total cases |
Country (no. cases) |
B.1.1.7* |
39 |
Pakistan (13), Philippines (8), United Kingdom (7), United Arab Emirates (3), India (2), Netherlands (2), Canada (1), Ireland (1), South Korea (1), Switzerland (1) |
B.1.351* |
7 |
Philippines (5), Bangladesh (1), United Kingdom/South Africa (1) |
B.1.526† |
1 |
United States (1) |
B.1.617† |
1 |
India (1) |
P.3† |
6 |
Philippines (6) |
Main Article
Page created: June 29, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.